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Abstract 
 
The search for new trypanocides has not been keenly pursued due to high cost of design and 
development with no promise of financial returns. Momordica balsamina fruit pulp extract was screened 
for antitrypanosomal activity in experimental T. brucei brucei infection in rabbits. The extract was 
administered prior to parasite inoculation, 24 hours post parasite inoculation and on establishment of 
infection. The treatment was by oral administration of the extract at 500mg/kg body weight for 14 
consecutive days. Parasitaemia was monitored daily while body weight and packed cell volume (PCV) 
were determined before commencement of studies and subsequently at weekly intervals for 28 days. The 
result showed a significant (P<0.05) delay in the establishment of T. b. brucei infection in rabbits treated at 
24 hours post parasite inoculation. Packed cell volume also increased significantly (P<0.05) in all treated 
groups when compared to the untreated group (control). This was less in the group treated on establishment 
of infection. Administration of the extract to the curative group resulted in body weight gain. The other 
groups suffered weight loss. The infected but not treated group died at day 39 post infection while those 
treated before parasite inoculation, 24hours post parasite inoculation, and on the establishment of infection 
survived for 45 days, 53 days, and 61 days respectively. We conclude that M. balsamina pulp extract 
reduces anaemia in experimentally infected rabbits. 
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Introduction 
 
Trypanosomiasis remains a major public health problem to man and his livestock over much of 
tropical Africa.  It is caused by Trypanosoma species.  The disease is difficult to treat and deadly, if 
untreated. It is difficult to estimate the overall burden of African trypanosomiasis because of under 
diagnosis in the most heavily infected countries. However, it is believed to be in the vicinity of 100,000 
new cases per year, with between ⅓ and ½ of cases remaining undetected and untreated (Pepin and Meda, 
2001). 
Chemotherapy is the most widely used means of controlling the disease.  However, effectiveness 
of the drugs available is limited by a number of factors, which include increasing parasite resistance 
(Afewerk et al., 2000) and treatment failures, unacceptable toxicity (Akanji and Ngaha, 1989; Triolo, 1990; 
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Onyekwelu, 1999) unavailability, logistics of administration, long period of treatment, and high cost. 
Furthermore, the high cost of developing new drugs, with little hope of a reasonable financial return for 
their investment in research and development, are serious disincentives for most pharmaceutical 
companies.  In the search for new trypanocides, a wide range of medicinal plants have been screened for 
antitrypanosomal activity and quite a number of them have been reported to have significant 
antitrypanosomal  activity (Adewumi et al., 2001; Ogbadoyi et al., 2007).  Momordica balsamina linn 
(Curcubitaceae) is an annual or perennial vine belonging to the family cucurbitaceous, indigenous to 
tropical Africa.  It has been used for various ailments and it is believed to possess significant immune 
boosting effect (Okeke, 2004) and also used as anti-tumor Bourinbaiar, 1995) and anti-HIV agent (Bot, 
2004).  The phytoconstituents of M. balsamina include glycoside, flavonoid, saponins and resins with 
glycosides highly present (Abubakar et al., 2005).  
There is a significant link between cancer and trypanosomiasis chemotherapy (Barret and Barret, 
2000). It is also known that the immune system of the host is usually overwhelmed due to antigenic 
variation. Since available information on the medicinal use of M. balsamina indicate that it possesses anti-
tumor and immune boosting effects, this study was aimed at screening the fruit pulp extract for possible 
antitrypanosomal property using T. b. brucei infected rabbit as a model. We report here that M. balsamina 
pulp extract has trypanostatic activity, reduces anaemia and promotes weight gain in experimental 
trypanosomiasis.  
 
 
Experimental 
Animals  
 
Adult male rabbits (1.69-2.94kg) were purchased from Miango, Plateau state, Nigeria. Animals 
were handled in compliance with internationally accepted standards for the humane treatment of animals.  
 
Trypanosomes 
 
Trypanosoma brucei brucei, Federe strain was isolated from cattle at Federe, in Plateau State, 
Nigeria, and preserved in liquid nitrogen in Parasitology Unit of the Nigerian Institute for Trypanosomiasis 
Research, Vom, Nigeria. 
  
Plant material 
 
Ripped M. balsamina fruits  were collected within and around Kaduna Vom, Plateau State, 
Nigeria in November 2006. The fruit was identified by Mallam Abdulkareem of the Federal College of 
Forestry, Jos, Plateau State, Nigeria, and a specimen was deposited in the college herbarium.    
 
 Preparation of the fruit pulp extract. 
 
Momordica balsamina fruit was cut into two and the pulp containing the seed squeezed out.  The 
seed was separated from the pulp using a wire mesh to obtain the pulp extract. The extract was dried in an 
oven at 50oC for 36 hrs. The yield was 32.11%. The dried extract was kept in the refrigerator until required. 
 
Parasite inoculation. 
 
Fifteen (15) adult male rabbits were weighed and divided into 5 groups (A – E) of 3 rabbits each.  
A stabilate of T. b. brucei taken from liquid nitrogen was inoculated into donor rats. Heavily infected blood 
sample from donor rats was collected through ocular vein puncture and immediately diluted with 
physiological saline to give 1x 10 7 parasites per ml to obtain inoculums. Healthy rabbits (groups A - D) 
were then inoculated with 0.1 ml of the diluted blood sample containing 1x106 trypanosome cells. Group A 
animals were pretreated with the extract for 14 consecutive days prior to parasite inoculation. Group E was 
not infected. Infection was monitored daily by wet film examination of blood sample taken from marginal 
ear veins of infected animals. 
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Administration of extract 
 
Administration of extract to group B commenced at 24 hrs post parasite inoculation while group C 
was at establishment of infection. Group D animals were only inoculated with the parasite but not treated 
with the extract while the group E animals were neither inoculated nor treated. Groups D and E served as 
positive and negative controls respectively. All administrations were through oral route at 500mg/kg body 
weight for 14 consecutive days. 
 
Therapeutic Effects of extract on infected animals 
 
This was done by monitoring the weight of all the animals, determining the packed cell volume 
(PCV), and parasitaemia of the animals. PCV was determined using the haematocrit centrifuge technique 
while parasitemia was determined daily as described by Herbert and Lumsden (1976). 
 
 
Results 
Parasitemia 
 
The results are presented in Figures 1-3. There were fluctuations in the level of parasitaemia of all 
the treated groups, which were however, kept at relatively very low level. The prepatent period for the 
group treated at 24 hours post parasite inoculation was 5-11 days while for other groups it was 5-7 days.  
When compared to the infected but untreated control, the treatment resulted into the prolongation of life by 
6, 14 and 22 days for groups A, B and C respectively.  Treatment of the infected group also resulted in the 
improvement in PCV when compared with the infected but untreated. The treated animals gained weight 
while the untreated animals suffered weight loss (Figures 4-6) 
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Figure 1: Changes in parasitaemia (×106/ml) of T. b. brucei infected rabbits and prophylactically treated  
               with M. balsamina pulp extract 
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Figure 2: Changes in parasitaemia (×106/ml) of T. b. brucei infected rabbits and treated at 24 hours post  
                inoculation with pulp extract of M. balsamina. 
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Figure 3: Changes in parasitaemia (×106/ml) of T. b.  brucei infected rabbits and treated with establishment 
                of infection with M. balsamina pulp extract 
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Figure 4: PCV and weight of infected rabbit and prophylactically treated with M. balsamina 
           pulp extract.  
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Figure 5: PCV and weight of infected rabbit and treated at 24 hours post inoculation with M. balsamina        
          pulp extract. 
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Figure 6: PCV and weight of infected and treated rabbit at the establishment of parasitaemia with M. 
balsamina pulp extract. 
 
 
 
Discussion 
 
The result of this study showed that M. balsamina pulp extract has potential in the management of 
African trypanosomiasis due to T. brucei.  The pulp extract of this plant has shown some level of 
antitrypanosomal activity by prolonging the prepatent period of animals treated after 24 hours post parasite 
inoculation.  There was also the extension of life of all the treated groups beyond that of the untreated 
control. However, it was observed that the prolongation of life conferred by the extract was highest in 
animals treated on the establishment of infection while the pretreated group recorded the least survival 
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period. What this suggests is that the extract strengthened the host defense, which was already activated 
because of the presence of parasites in circulation in the rabbits with established infection. This observation 
is of particular interest because M. balsamina pulp extract was earlier reported to boost immune system 
(Okeke, 2004). It is therefore likely that the pulp was able to elicit the production of antibodies in the 
presence of parasites in circulation. This, taken together with the longer prepatent period observed in 24 hrs 
treated animals suggests that the extract may positively influence the defense capacity of the treated 
animals. It may well be that the extract enhanced phygocytosis. The net effect of all these was the resultant 
prolongation of the lives of the treated animals as a consequence of the parasites being kept in check.  
The observed trypanostatic effect of the extract was accompanied by corresponding increase in 
PCV.  Anaemia is the most outstanding clinical and laboratory feature of African trypanosomiasis (Suliman 
and Fieldman, 1989) and also the primary cause of death (Losos and Ikede, 1972; Mamo and Holmes, 
1975). Anemia as indicated by PCV level is known to worsen with increasing parasitaemia (Ogbadoyi et 
al., 1999). The prolongation of lives of treated animals may therefore also be associated with the ability of 
this extract to improve the PCV possibly by reducing the parasite load or neutralizing the toxic metabolites 
produced by trypanosomes.   
The positive effect of the extract particularly on the curative group can further be deduced from 
the weight status of the animals.  At two weeks post treatment, animals in the curative group gained weight 
by 1%; while the pretreated group and the group treated 24 hrs post parasite inoculation lost weight by 
12.3% and 7.9% respectively. This observation indicates that the animals in the curative group were in a 
better physical state to eat more than those in the other groups. They were therefore more able to resist 
weight loss that is usually associated with trypanosomiasis. 
M. balsamina pulp extract has being reported to have anti-tumor, anti-HIV, and antiplasmodial 
effects (Bourinbaiar, 1995; Bot, 2004, Benoit-Vical et al., 2006 ). These reports are of interest to us in two 
respects. The anti-tumour activity is particularly exciting because all four drugs currently used clinically in 
the treatment of sleeping sickness are known to have some level of anti-cancer activities (Barret and Barret, 
2000). Hitherto, drug developers are reluctant to invest in research and development of drugs for the 
treatment of African trypanosomiasis alone for lack of profitable market. 
Therefore, the antiplasmodial and anti-HIV activities taken together with the anti-tumour activity may 
generate the much needed interest in potential investors to invest in research and development of 
ethnomedicine and/or synthesis of modern pharmaceuticals from lead compounds that may be obtained 
from extracts of this plant.  
In conclusion, this study has provided evidence that M. balsamina fruit pulp extract is 
trypanostatic, reduces anemia and promotes weight gain in experimental African trypanosomiasis. It is 
potentially a useful antitrypanosomal agent. Further work is in progress to determine the full effect it has on 
larpine trypanosomiasis. 
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